• Home
  • Eua Authorized Lifesign Covid-19 / Flu A&B

Eua Authorized Lifesign Covid-19 / Flu A&B

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens

Part #: 33225

Units of Measure: Box

QuantityPrice
1 - 999999$1,784.65
1000000 +$1,444.40

Details

Details

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen

  • Sensitivity and Specificity
    − COVID-19 - Sensitivity 93.9%, Specificity 100%
    − Flu A - Sensitivity 91.4%, Specificity 95.7%
    − Flu B - Sensitivity 87.6%, Specificity 95.9%
  • FDA Emergency Use Authorization (EUA)
  • Visually read in 15 minutes
  • Flocked nasopharyngeal swab for superior specimen collection and patient comfort

CPT COVID-19: 87811QW
FLU A: 87804QW
FLU B: 87804QW-59